Aerie Pharmaceuticals Inc is categorized under Biological Research in Durham, NC .
Aerie Pharmaceuticals Inc was established in 0, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Thomas Van Haarlem, President at the company’s branch by writing to 7020 Kit Creek Road # 270, Durham, North Carolina NC 27709 or by phoning (919) 313-9650. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Aerie Pharmaceuticals Inc |
| Contact Person: | Thomas Van Haarlem, President |
| Address: | 7020 Kit Creek Road # 270, Durham, North Carolina 27709 |
| Phone Number: | (919) 313-9650 |
| Website Address: | aeriepharma.com |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Research |
| SIC Code: | 8731 |
| NAICS Code: | 4242101 |
| Share This Business: |
Aerie Pharmaceuticals Inc was started in 0 to provide professional Biological Research under the SIC code 8731 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Thomas Van Haarlem, President for inquiries that concern Aerie Pharmaceuticals Inc by calling the company number (919) 313-9650, as your correspondence is most welcome. Additionally, the physical location of the branch of Aerie Pharmaceuticals Inc can be found at the coordinates 35.90594,-78.86228 as well as the street address 7020 Kit Creek Road # 270 in Durham, North Carolina 27709.
For its online presence, you may visit Aerie Pharmaceuticals Inc’s website at aeriepharma.com and engage with its social media outlets through on Twitter and on Facebook.